GE Healthcare: Pharmaceuticals and Healthcare Company Profile & SWOT ReportiCD ResearchFebruary 6, 2012 55 Pages - SKU: ICDR6793233 |
| Synopsis ICD Research's GE Healthcare: Pharmaceuticals and Healthcare Company Profile & SWOT Report contains in depth information and data about the company and its operations. The profile contains a company overview, business description, SWOT analysis, key facts, information on products and services, details of locations and subsidiaries, plus information on key news events affecting the company. Summary ICD Research's GE Healthcare: Pharmaceuticals and Healthcare Company Profile & SWOT Report is a crucial resource for industry executives and anyone looking to access key information about GE Healthcare. ICD Research's GE Healthcare: Pharmaceuticals and Healthcare Company Profile & SWOT Report report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report. Scope
GE Healthcare, (formerly known as GE Medical Systems), provides transformational medical technologies and professional consulting services, focusing on enhancing patient care. The company principally focuses on medical imaging and information technologies, medical diagnostics, patient monitoring systems, performance improvement, drug discovery, and biopharmaceutical manufacturing technologies. GE Healthcare's products and services are aimed at improving healthcare providers' ability to diagnose and treat cancer, heart disease, neurological diseases and other conditions in the initial stages. The company's products and services are available across more than 100 countries across North America, Europe, Asia, Australia and South America regions. GE Healthcare is headquartered in Buckinghamshire, the UK. |
Related Markets
Pharmaceuticals Company Reports
- Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q1 2012
- Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics
- Royalty Financing Terms and Agreements in Pharma, Biotech and Diagnostics
- Partnerships, Licensing, Investments and M&A Deals and Trends for March 2012 in Pharmaceuticals
- Contract Research Organizations (CROs) Market to 2018 - Public-Private Partnerships to Strengthen Research Capacities and Advance Clinical Development Programs

